SOLVENTUM CORP (SOLV) Stock Fundamental Analysis

NYSE:SOLV • US83444M1018

72.94 USD
-0.67 (-0.91%)
At close: Feb 20, 2026
72.7 USD
-0.24 (-0.33%)
After Hours: 2/20/2026, 8:05:38 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Taking everything into account, SOLV scores 4 out of 10 in our fundamental rating. SOLV was compared to 185 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of SOLV while its profitability can be described as average. SOLV has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year SOLV was profitable.
  • In the past year SOLV had a positive cash flow from operations.
SOLV Yearly Net Income VS EBIT VS OCF VS FCFSOLV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

  • SOLV has a better Return On Assets (10.91%) than 94.59% of its industry peers.
  • SOLV has a Return On Equity of 30.57%. This is amongst the best in the industry. SOLV outperforms 98.92% of its industry peers.
  • SOLV's Return On Invested Capital of 5.13% is fine compared to the rest of the industry. SOLV outperforms 76.22% of its industry peers.
  • SOLV had an Average Return On Invested Capital over the past 3 years of 9.85%. This is in line with the industry average of 8.75%.
  • The last Return On Invested Capital (5.13%) for SOLV is well below the 3 year average (9.85%), which needs to be investigated, but indicates that SOLV had better years and this may not be a problem.
Industry RankSector Rank
ROA 10.91%
ROE 30.57%
ROIC 5.13%
ROA(3y)7.62%
ROA(5y)N/A
ROE(3y)13.05%
ROE(5y)N/A
ROIC(3y)9.85%
ROIC(5y)N/A
SOLV Yearly ROA, ROE, ROICSOLV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 5 10 15

1.3 Margins

  • SOLV's Profit Margin of 18.14% is amongst the best of the industry. SOLV outperforms 94.05% of its industry peers.
  • In the last couple of years the Profit Margin of SOLV has declined.
  • The Operating Margin of SOLV (8.44%) is better than 75.68% of its industry peers.
  • SOLV's Operating Margin has declined in the last couple of years.
  • SOLV has a Gross Margin (54.18%) which is comparable to the rest of the industry.
  • SOLV's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.44%
PM (TTM) 18.14%
GM 54.18%
OM growth 3Y-16.68%
OM growth 5YN/A
PM growth 3Y-31.26%
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5YN/A
SOLV Yearly Profit, Operating, Gross MarginsSOLV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SOLV is destroying value.
  • The number of shares outstanding for SOLV remains at a similar level compared to 1 year ago.
  • SOLV has a worse debt/assets ratio than last year.
SOLV Yearly Shares OutstandingSOLV Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 50M 100M 150M
SOLV Yearly Total Debt VS Total AssetsSOLV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 5B 10B

2.2 Solvency

  • An Altman-Z score of 1.91 indicates that SOLV is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 1.91, SOLV perfoms like the industry average, outperforming 59.46% of the companies in the same industry.
  • SOLV has a debt to FCF ratio of 102.74. This is a negative value and a sign of low solvency as SOLV would need 102.74 years to pay back of all of its debts.
  • SOLV's Debt to FCF ratio of 102.74 is fine compared to the rest of the industry. SOLV outperforms 66.49% of its industry peers.
  • SOLV has a Debt/Equity ratio of 1.03. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of SOLV (1.03) is worse than 76.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 102.74
Altman-Z 1.91
ROIC/WACC0.51
WACC10.12%
SOLV Yearly LT Debt VS Equity VS FCFSOLV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 1.50 indicates that SOLV should not have too much problems paying its short term obligations.
  • The Current ratio of SOLV (1.50) is worse than 75.14% of its industry peers.
  • A Quick Ratio of 1.14 indicates that SOLV should not have too much problems paying its short term obligations.
  • SOLV has a worse Quick ratio (1.14) than 71.35% of its industry peers.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.14
SOLV Yearly Current Assets VS Current LiabilitesSOLV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 108.76% over the past year.
  • The earnings per share for SOLV have been decreasing by -31.19% on average. This is quite bad
  • Looking at the last year, SOLV shows a small growth in Revenue. The Revenue has grown by 2.28% in the last year.
  • SOLV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.34% yearly.
EPS 1Y (TTM)108.76%
EPS 3Y-31.19%
EPS 5YN/A
EPS Q2Q%-8.54%
Revenue 1Y (TTM)2.28%
Revenue growth 3Y0.34%
Revenue growth 5YN/A
Sales Q2Q%0.67%

3.2 Future

  • The Earnings Per Share is expected to grow by 4.39% on average over the next years.
  • The Revenue is expected to grow by 0.73% on average over the next years.
EPS Next Y-8.14%
EPS Next 2Y-1.62%
EPS Next 3Y1.71%
EPS Next 5Y4.39%
Revenue Next Year0.54%
Revenue Next 2Y-1.35%
Revenue Next 3Y0.17%
Revenue Next 5Y0.73%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SOLV Yearly Revenue VS EstimatesSOLV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B
SOLV Yearly EPS VS EstimatesSOLV Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 12.28 indicates a correct valuation of SOLV.
  • Compared to the rest of the industry, the Price/Earnings ratio of SOLV indicates a rather cheap valuation: SOLV is cheaper than 92.97% of the companies listed in the same industry.
  • SOLV is valuated cheaply when we compare the Price/Earnings ratio to 26.99, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 11.27, the valuation of SOLV can be described as reasonable.
  • Based on the Price/Forward Earnings ratio, SOLV is valued cheaper than 93.51% of the companies in the same industry.
  • SOLV is valuated cheaply when we compare the Price/Forward Earnings ratio to 28.06, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.28
Fwd PE 11.27
SOLV Price Earnings VS Forward Price EarningsSOLV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • SOLV's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. SOLV is cheaper than 85.41% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, SOLV is valued a bit cheaper than the industry average as 67.03% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 253.03
EV/EBITDA 13.12
SOLV Per share dataSOLV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.62%
EPS Next 3Y1.71%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for SOLV!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SOLVENTUM CORP

NYSE:SOLV (2/20/2026, 8:05:38 PM)

After market: 72.7 -0.24 (-0.33%)

72.94

-0.67 (-0.91%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-06
Earnings (Next)02-26
Inst Owners72.36%
Inst Owner ChangeN/A
Ins Owners0.13%
Ins Owner Change0.32%
Market Cap12.65B
Revenue(TTM)8.40B
Net Income(TTM)1.52B
Analysts75.24
Price Target91.16 (24.98%)
Short Float %2.48%
Short Ratio3.57
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.87%
Min EPS beat(2)2.66%
Max EPS beat(2)15.09%
EPS beat(4)4
Avg EPS beat(4)7.48%
Min EPS beat(4)2.66%
Max EPS beat(4)15.09%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.07%
Min Revenue beat(2)-0.05%
Max Revenue beat(2)0.19%
Revenue beat(4)2
Avg Revenue beat(4)0%
Min Revenue beat(4)-0.81%
Max Revenue beat(4)0.68%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.82%
PT rev (3m)5.87%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.12%
EPS NY rev (1m)0%
EPS NY rev (3m)1.32%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.09%
Valuation
Industry RankSector Rank
PE 12.28
Fwd PE 11.27
P/S 1.51
P/FCF 253.03
P/OCF 25.66
P/B 2.54
P/tB N/A
EV/EBITDA 13.12
EPS(TTM)5.94
EY8.14%
EPS(NY)6.47
Fwd EY8.88%
FCF(TTM)0.29
FCFY0.4%
OCF(TTM)2.84
OCFY3.9%
SpS48.44
BVpS28.75
TBVpS-14.4
PEG (NY)N/A
PEG (5Y)N/A
Graham Number61.98
Profitability
Industry RankSector Rank
ROA 10.91%
ROE 30.57%
ROCE 6.43%
ROIC 5.13%
ROICexc 6.03%
ROICexgc 29.65%
OM 8.44%
PM (TTM) 18.14%
GM 54.18%
FCFM 0.6%
ROA(3y)7.62%
ROA(5y)N/A
ROE(3y)13.05%
ROE(5y)N/A
ROIC(3y)9.85%
ROIC(5y)N/A
ROICexc(3y)10.1%
ROICexc(5y)N/A
ROICexgc(3y)49.33%
ROICexgc(5y)N/A
ROCE(3y)12.33%
ROCE(5y)N/A
ROICexgc growth 3Y-14.04%
ROICexgc growth 5YN/A
ROICexc growth 3Y-12.55%
ROICexc growth 5YN/A
OM growth 3Y-16.68%
OM growth 5YN/A
PM growth 3Y-31.26%
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5YN/A
F-Score6
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 102.74
Debt/EBITDA 4.17
Cap/Depr 84.87%
Cap/Sales 5.27%
Interest Coverage 250
Cash Conversion 40.05%
Profit Quality 3.28%
Current Ratio 1.5
Quick Ratio 1.14
Altman-Z 1.91
F-Score6
WACC10.12%
ROIC/WACC0.51
Cap/Depr(3y)54.53%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.74%
Cap/Sales(5y)N/A
Profit Quality(3y)131.71%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)108.76%
EPS 3Y-31.19%
EPS 5YN/A
EPS Q2Q%-8.54%
EPS Next Y-8.14%
EPS Next 2Y-1.62%
EPS Next 3Y1.71%
EPS Next 5Y4.39%
Revenue 1Y (TTM)2.28%
Revenue growth 3Y0.34%
Revenue growth 5YN/A
Sales Q2Q%0.67%
Revenue Next Year0.54%
Revenue Next 2Y-1.35%
Revenue Next 3Y0.17%
Revenue Next 5Y0.73%
EBIT growth 1Y-45.71%
EBIT growth 3Y-16.4%
EBIT growth 5YN/A
EBIT Next Year17.61%
EBIT Next 3Y6.96%
EBIT Next 5Y3.32%
FCF growth 1Y-50.46%
FCF growth 3Y-25.22%
FCF growth 5YN/A
OCF growth 1Y-38.12%
OCF growth 3Y-18.66%
OCF growth 5YN/A

SOLVENTUM CORP / SOLV FAQ

Can you provide the ChartMill fundamental rating for SOLVENTUM CORP?

ChartMill assigns a fundamental rating of 4 / 10 to SOLV.


What is the valuation status of SOLVENTUM CORP (SOLV) stock?

ChartMill assigns a valuation rating of 6 / 10 to SOLVENTUM CORP (SOLV). This can be considered as Fairly Valued.


Can you provide the profitability details for SOLVENTUM CORP?

SOLVENTUM CORP (SOLV) has a profitability rating of 5 / 10.


How financially healthy is SOLVENTUM CORP?

The financial health rating of SOLVENTUM CORP (SOLV) is 3 / 10.